| Name | Title | Contact Details |
|---|
Floyd Lee Locums provides an elite concierge experience to physicians, CRNAs, nurse practitioners, physician assistants, and other healthcare providers searching for new career opportunities. Founded by industry veterans Matt Floyd and Natasha Lee, Floyd Lee Locums is a locum tenens healthcare staffing organization with over 60 years of combined experience.
Maryland Health Benefit Exchange’s (MHBE) resource site for stakeholders. We continue to work toward the opening of the marketplace in October 2013 of Maryland Health Connection, the state-based health insurance exchange where Maryland residents and small businesses will be able to explore and compare health insurance plans, qualify for cost-sharing reductions and tax credits and complete the enrollment process. The information available through this site supports our work with stakeholders. Meeting schedules and materials, career information, and procurement details are routinely posted. Additionally, the site serves as a resource for the many advisory committees and programs in progress and in development as we collectively work together to establish a health insurance marketplace that best meets the needs of all Marylanders.
Dallas Retirement Village is a Dallas, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.